Advertisement

Forensic Toxicology

, Volume 32, Issue 1, pp 75–81 | Cite as

An LC–MS–MS method for quantitation of four new phenethylamines (BOX series) in plasma: in vivo application

  • Gianpiero Boatto
  • Maria Antonietta Pirisi
  • Lucia Burrai
  • Elena Baralla
  • Maria Piera Demontis
  • Maria Vittoria Varoni
  • Maria NiedduEmail author
Original Article

Abstract

The appearance of new “designer drugs” in the illicit market poses a serious health risk because they have unknown safety profiles, have a high potential for abuse, high potency, and can lead to devastating health consequences. For this reason, it is desirable to develop validated and reliable analytical screening tests that allow detection of amphetamines and related designer drugs in biological samples. We report a method for separation and quantitation of four new phenethylamines, 4-bromo-2,5-beta-trimethoxyphenethylamine (BOB), 4-methyl-2,5-beta-trimethoxyphenethylamine (BOD), 3,4-methylenedioxy-beta-methoxyphenethylamine (BOH), and 4-methyl-2,5-dimethoxy-beta-hydroxyphenethylamine (BOHD), in plasma. Quantitation was achieved via liquid chromatography–tandem mass spectrometry (LC–MS–MS) in the multiple reaction monitoring mode, using 2,3-dimethoxyphenethylamine-d 3 as internal standard. The method was validated according to international guidelines. The parameters determined were selectivity, sensitivity, matrix effect, linearity, precision, recovery, and stability. All parameters were satisfactory. To remove matrix interference, solid-phase extraction was introduced in the method as clean-up step. The same method was applied in a pharmacokinetic study to monitor the target compounds in rat plasma after a single oral administration. The developed and validated LC–MS–MS method is the first available for quantitation of BOB, BOH, BOD, and BOHD in a biological matrix. This method is recommended for use in forensic and clinical toxicology, because of its sensitivity, selectivity, and simplicity. An important extension of this method could involve its application to other complex matrices.

Keywords

BOX series Phenethylamines LC–MS–MS Plasma Pharmacokinetic profile 

Notes

Acknowledgments

The authors are grateful to the Language Centre of Sassari University for the English editing of the manuscript.

Conflict of interest

There are no financial or other relations that could lead to a conflict of interest.

References

  1. 1.
    European Monitoring Centre for Drugs and Drug Addiction (2012) Annual report on the state of the drugs problem in the European Union. European Monitoring Centre for Drugs and Drug Addiction, LisbonGoogle Scholar
  2. 2.
    Nieddu M, Trignano C, Burrai L, Pirisi MA, Boatto G (2013) Cross-reactivities of 41 new amphetamine-designer drugs to EMIT® immunoassays. Forensic Toxicol 31:133–137CrossRefGoogle Scholar
  3. 3.
    Shiotsuki T, Yoshitome K, Moriya F (2012) Use of on-site immunoassay devices to screen urine absorbed in disposable diapers for methamphetamine: a preliminary study with artificial urine. Forensic Toxicol 30:162–167CrossRefGoogle Scholar
  4. 4.
    Nakanishi K, Miki A, Zaitsu K, Kamata H, Shima N, Kamata T, Katagi M, Tatsuno M, Tsuchihashi H, Suzuki K (2012) Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Sci Int 217:174–181PubMedCrossRefGoogle Scholar
  5. 5.
    Shima N, Katagi M, Kamata H, Zaitsu K, Kamata T, Miki A, Tsuchihashi H, Sakuma T, Nemoto N (2008) Conjugates of p-hydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine in blood obtained from methamphetamine and 3,4-methylenedioxymethamphetamine users: analysis by LC–MS–MS. Forensic Toxicol 26:58–65CrossRefGoogle Scholar
  6. 6.
    Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (2013) Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry. Forensic Toxicol 31:241–250CrossRefGoogle Scholar
  7. 7.
    Nieddu M, Boatto G, Pirisi MA, Baralla E (2009) Multi-residue analysis of eight thioamphetamine designer drugs in human urine by LC–MS/MS. Rapid Commun Mass Spectrom 23:3051–3056PubMedCrossRefGoogle Scholar
  8. 8.
    Nieddu M, Burrai L, Pirisi MA, Carta A, Briguglio I, Dessì G, Boatto G (2013) Validated liquid chromatography-mass spectrometry method for the quantitation of N-substitute derivatives of 3,4-methylenedioxyamphetamines in rat urine. Forensic Toxicol 31:204–211CrossRefGoogle Scholar
  9. 9.
    Pirisi MA, Nieddu M, Burrai L, Carta A, Briguglio I, Baralla E, Demontis MP, Varoni MV, Boatto G (2013) An LC–MS–MS method for quantitative analysis of six trimethoxyamphetamine designer drugs in rat plasma, and its application to a pharmacokinetic study. Forensic Toxicol 31:197–203CrossRefGoogle Scholar
  10. 10.
    Shulgin A, Shulgin A (1991) Pihkal, a chemical love story. Transform Press, BerkeleyGoogle Scholar
  11. 11.
    Peters FT, Maureer HH (2002) Bioanalytical method validation and its implications for forensic and clinical toxicology. Accred Qual Assur 7:441–444CrossRefGoogle Scholar
  12. 12.
    Taverniers I, de Loose M, Van Bockstaele E (2004) Analytical method validation and quality assurance. Trends Anal Chem 23:533–536Google Scholar
  13. 13.
    Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216–224PubMedCrossRefGoogle Scholar
  14. 14.
    Souverain S, Rudaz S, Veuthey JL (2004) Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures. J Chromatogr A 1058:61–66PubMedGoogle Scholar
  15. 15.
    Annesley T (2003) Ion suppression in mass spectrometry. Clin Chem 49:1041–1044PubMedCrossRefGoogle Scholar
  16. 16.
    Maureer HH (2007) Current role of liquid chromatography–mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem 388:1315–1325CrossRefGoogle Scholar

Copyright information

© Japanese Association of Forensic Toxicology and Springer Japan 2013

Authors and Affiliations

  • Gianpiero Boatto
    • 1
  • Maria Antonietta Pirisi
    • 1
  • Lucia Burrai
    • 1
  • Elena Baralla
    • 2
  • Maria Piera Demontis
    • 2
  • Maria Vittoria Varoni
    • 2
  • Maria Nieddu
    • 1
    Email author
  1. 1.Dipartimento di Chimica e FarmaciaUniversità di SassariSassariItaly
  2. 2.Dipartimento di Medicina VeterinariaUniversità di SassariSassariItaly

Personalised recommendations